Introduction: The aim of this study was to determine the long-term survival of patients operated for gastric cancer at Oslo University Hospital, Ullevål during the period 1982-2005.
Methods: We have retrospectively analyzed medical journal of a total of 114 patients operated for gastric cancer. Only patients with adenocarcinoma who underwent a R0-R2 resection were included.
Results: A total of 81 patients were eligible for inclusion. The median age at the time of diagnosis was 70 years (26-86 years) and the median follow-up after surgery was 20 months (0, 3-266 months). The resection rate was 71, 1 %. Estimated 5-year survival for R0-R2 resection was 33, 8 % and 40, 0 % for R0 resection (p = 0, 51). There was no significant difference in 5-year survival between tumors located in the cardia and other parts of the stomach (p = 0, 22). 30-day mortality was 6, 2 %. 17, 3 % of the patients experienced postoperative complications. A median of 1 of 7 lymph nodes (0-21 lymph nodes) that were evaluated contined metastasis. Stage specific (UICC) survival was estimated.
Conclusion: Patients operated for gastric cancer at Oslo University Hospital, Ullevål between 1982-2005 experienced a long-term survival, 30-day mortality and complications rate postoperatively within the recommendations of the Norwegian guidelines for treatment of gastric cancer. The results are comparable with other national and international studies.